Literature DB >> 12575016

Circulating trophoblast in maternal blood.

Cees B M Oudejans1, May Lee Tjoa, Bart A Westerman, Monique A M Mulders, Inge J Van Wijk, John M G Van Vugt.   

Abstract

This review describes the status of circulating trophoblast, but is considered in the perspective that only a specific subset of trophoblast cells circulates in the maternal blood. The consequences for isolation, identification and clinical potential are described. Copyright 2003 John Wiley & Sons, Ltd.

Mesh：

Year:  2003        PMID： 12575016     DOI： 10.1002/pd.539

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN： 0197-3851            Impact factor:   3.050


  9 in total

Review 1.  Recent developments in fetal medicine.

Authors:  Sailesh Kumar; Anna O'Brien
Journal:  BMJ       Date:  2004-04-24

Review 2.  Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency.

Authors:  Ilona Hromadnikova
Journal:  DNA Cell Biol       Date:  2012-02-24       Impact factor: 3.311

3.  Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Marketa Ondrackova; Petra Pirkova; Andrea Kestlerova; Veronika Novotna; Lucie Hympanova; Ladislav Krofta
Journal:  DNA Cell Biol       Date:  2015-03-31       Impact factor: 3.311

4.  Sensitive and high-throughput isolation of rare cells from peripheral blood with ensemble-decision aliquot ranking.

Authors:  Perry G Schiro; Mengxia Zhao; Jason S Kuo; Karen M Koehler; Daniel E Sabath; Daniel T Chiu
Journal:  Angew Chem Int Ed Engl       Date:  2012-02-22       Impact factor: 15.336

5.  First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Lucie Hympanova; Jindrich Doucha; Ladislav Krofta
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

6.  Fetal gender and several cytokines are associated with the number of fetal cells in maternal blood--an observational study.

Authors:  Jacob Mørup Schlütter; Ida Kirkegaard; Olav Bjørn Petersen; Nanna Larsen; Britta Christensen; David M Hougaard; Steen Kølvraa; Niels Uldbjerg
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

7.  Circulating C19MC microRNAs in preeclampsia, gestational hypertension, and fetal growth restriction.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Marketa Ondrackova; Andrea Kestlerova; Veronika Novotna; Lucie Hympanova; Jindrich Doucha; Ladislav Krofta
Journal:  Mediators Inflamm       Date:  2013-11-14       Impact factor: 4.711

8.  Evidence for feasibility of fetal trophoblastic cell-based noninvasive prenatal testing.

Authors:  Amy M Breman; Jennifer C Chow; Lance U'Ren; Elizabeth A Normand; Sadeem Qdaisat; Li Zhao; David M Henke; Rui Chen; Chad A Shaw; Laird Jackson; Yaping Yang; Liesbeth Vossaert; Rachel H V Needham; Elizabeth J Chang; Daniel Campton; Jeffrey L Werbin; Ron C Seubert; Ignatia B Van den Veyver; Jackie L Stilwell; Eric P Kaldjian; Arthur L Beaudet
Journal:  Prenat Diagn       Date:  2016-10-02       Impact factor: 3.050

9.  First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Katarina Ivankova; Ladislav Krofta
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.